328 related articles for article (PubMed ID: 14500736)
1. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
[TBL] [Abstract][Full Text] [Related]
2. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
Odagaki Y; Kinoshita M; Toyoshima R
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
[TBL] [Abstract][Full Text] [Related]
5. Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.
Rowe BA; Schaffhauser H; Morales S; Lubbers LS; Bonnefous C; Kamenecka TM; McQuiston J; Daggett LP
J Pharmacol Exp Ther; 2008 Jul; 326(1):240-51. PubMed ID: 18430863
[TBL] [Abstract][Full Text] [Related]
6. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Litschig S; Gasparini F; Rueegg D; Stoehr N; Flor PJ; Vranesic I; Prézeau L; Pin JP; Thomsen C; Kuhn R
Mol Pharmacol; 1999 Mar; 55(3):453-61. PubMed ID: 10051528
[TBL] [Abstract][Full Text] [Related]
7. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors.
Hemstapat K; Da Costa H; Nong Y; Brady AE; Luo Q; Niswender CM; Tamagnan GD; Conn PJ
J Pharmacol Exp Ther; 2007 Jul; 322(1):254-64. PubMed ID: 17416742
[TBL] [Abstract][Full Text] [Related]
8. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
[TBL] [Abstract][Full Text] [Related]
9. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
Nikiforuk A; Popik P; Drescher KU; van Gaalen M; Relo AL; Mezler M; Marek G; Schoemaker H; Gross G; Bespalov A
J Pharmacol Exp Ther; 2010 Dec; 335(3):665-73. PubMed ID: 20739457
[TBL] [Abstract][Full Text] [Related]
10. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
[TBL] [Abstract][Full Text] [Related]
11. Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus.
Losonczy A; Somogyi P; Nusser Z
J Neurophysiol; 2003 Apr; 89(4):1910-9. PubMed ID: 12686572
[TBL] [Abstract][Full Text] [Related]
12. Group II metabotropic glutamate receptor-mediated activation of G-proteins in rat hippocampal and striatal membranes.
Odagaki Y; Kinoshita M; Toyoshima R
Neurosci Lett; 2013 Feb; 539():22-6. PubMed ID: 23384570
[TBL] [Abstract][Full Text] [Related]
13. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.
Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD
J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748
[TBL] [Abstract][Full Text] [Related]
14. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
15. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.
Kinney GG; O'Brien JA; Lemaire W; Burno M; Bickel DJ; Clements MK; Chen TB; Wisnoski DD; Lindsley CW; Tiller PR; Smith S; Jacobson MA; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
J Pharmacol Exp Ther; 2005 Apr; 313(1):199-206. PubMed ID: 15608073
[TBL] [Abstract][Full Text] [Related]
16. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
17. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
[TBL] [Abstract][Full Text] [Related]
18. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site.
Knoflach F; Mutel V; Jolidon S; Kew JN; Malherbe P; Vieira E; Wichmann J; Kemp JA
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13402-7. PubMed ID: 11606768
[TBL] [Abstract][Full Text] [Related]
19. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain.
O'Brien JA; Lemaire W; Wittmann M; Jacobson MA; Ha SN; Wisnoski DD; Lindsley CW; Schaffhauser HJ; Rowe B; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
J Pharmacol Exp Ther; 2004 May; 309(2):568-77. PubMed ID: 14747613
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
